Status:
UNKNOWN
A Multicentre Trial of Nerve-Spring Radical Hysterectomy vs. Radical Hysterectomy for Cervical Cancer
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Collaborating Sponsors:
Tumor Hospital of Xin Jiang Medical University,China
Gui Yang Maternal and Child Health Hospital,China
Conditions:
Cervical Cancer
Eligibility:
FEMALE
17-60 years
Phase:
NA
Brief Summary
The investigators designed this multicentre randomized study to investigate the clinical benefits of nerve-spring radical hysterectomy for cervical cancer. Patients with FIGO stage Ia2, Ib1, IIa1 and ...
Eligibility Criteria
Inclusion
- FIGO(2009) stage Ia2, Ib1, and IIa1 Untreated cervical cancer OR FIGO(2009) stage Ib2 and IIa2 cervical cancer that possible to surgery after neoadjuvant chemotherapy
- Possible to radical hysterectomy or nerve-spring radical hysterectomy
- Age: 17 to 60 years
- No complication during operation
- Written informed consent
Exclusion
- patients who underwent radiotherapy
- Pathologically diagnosed Pathologically diagnosed squamous carcinoma, Small Cell Carcinoma, Small Cell Carcinoma
- Patients who have uncontrolled diabetes or uncontrolled hypertension
- patients with neurogenic bladder dysfunction
- patients with uterine prolapse
- Patients with psychiatric illness
- Patients who have active infection
- Patients who have had heart failure, unstable angina, or myocardial infarction within the past 6 months
- Patients who are unable to undergo radical hysterectomy for complication of excessive obesity, liver cirrhosis, or bleeding tendency
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT01886508
Start Date
July 1 2013
End Date
December 1 2020
Last Update
July 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern Medical University, China
Guangzhou, Guangdong, China, 510515